Crossmark

“Is Eptinezumab the Key to Reducing Chronic Migraine Disability?”

Crossref DOI link: https://doi.org/10.1007/s42399-024-01745-8

Published Online: 2024-11-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shahid, Sufyan https://orcid.org/0009-0002-9236-0822
Iqbal, Minahil https://orcid.org/0000-0002-9320-1228
License Information

Text and Data Mining valid from 2024-11-07

Version of Record valid from 2024-11-07
More Information

Article History

Accepted: 29 October 2024

First Online: 7 November 2024

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.